Adaptive Biotechnologies Corporation
ADPT
$17.50
$0.724.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 218.33M | 226.98M | 212.77M | 197.87M | 193.42M |
| Total Receivables | 49.92M | 51.87M | 46.32M | 45.59M | 45.08M |
| Inventory | 11.21M | 9.82M | 9.93M | 8.40M | 8.68M |
| Prepaid Expenses | 12.35M | 11.52M | 12.41M | 10.00M | 9.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 291.81M | 300.19M | 281.44M | 261.86M | 256.49M |
|
|
|||||
| Total Current Assets | 291.81M | 300.19M | 281.44M | 261.86M | 256.49M |
| Net Property, Plant & Equipment | 71.02M | 74.72M | 79.49M | 84.39M | 88.43M |
| Long-term Investments | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M |
| Goodwill | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M |
| Total Other Intangibles | 1.31M | 1.73M | 2.16M | 2.58M | 3.01M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.95M | 3.90M | 4.53M | 4.73M | 4.60M |
| Total Assets | 505.94M | 512.74M | 490.61M | 496.64M | 510.85M |
|
|
|||||
| Total Accounts Payable | 9.62M | 6.47M | 10.27M | 6.91M | 6.36M |
| Total Accrued Expenses | 13.68M | 22.72M | 19.89M | 16.91M | 14.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.32M | 13.56M | 11.87M | 13.03M | 12.47M |
| Total Finance Division Other Current Liabilities | 49.40M | 47.17M | 41.34M | 55.30M | 54.81M |
| Total Other Current Liabilities | 49.40M | 47.17M | 41.34M | 55.30M | 54.81M |
| Total Current Liabilities | 87.01M | 89.92M | 83.36M | 92.14M | 87.81M |
|
|
|||||
| Total Current Liabilities | 87.01M | 89.92M | 83.36M | 92.14M | 87.81M |
| Long-Term Debt | 124.75M | 126.57M | 129.41M | 130.50M | 131.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 69.12M | 70.23M | 72.36M | 74.41M | 76.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 827.00K | 1.03M | 1.23M | 20.05M | 24.83M |
| Total Liabilities | 281.70M | 287.74M | 286.36M | 317.10M | 320.63M |
|
|
|||||
| Common Stock & APIC | 1.60B | 1.58B | 1.55B | 1.54B | 1.52B |
| Retained Earnings | -1.38B | -1.36B | -1.35B | -1.36B | -1.33B |
| Treasury Stock & Other | -28.00K | 253.00K | 211.00K | 73.00K | 134.00K |
| Total Common Equity | 216.34M | 218.79M | 204.44M | 179.72M | 190.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 216.34M | 218.79M | 204.44M | 179.72M | 190.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 7.90M | 6.21M | -182.00K | -181.00K | -202.00K |
| Total Equity | 224.24M | 225.00M | 204.25M | 179.54M | 190.22M |
|
|
|||||